Bone Morphogenic Proteins and their antagonists in the lower airways of stable COPD patients
A. Di Stefano (Veruno (NO), Italy), I. Gnemmi (Veruno (NO), Italy), F. Dossena (Veruno (NO), Italy), U. Rosani (Padova, Italy), P. Brun (Padova, Italy), A. Leonardi (Padova, Italy), B. Balbi (Padova, Italy), F. Nucera (Messina, Italy), V. Carriero (Torino, Italy), F. Bertolini (Torino, Italy), S. D'Anna (Telese, Italy), M. Maniscalco (Telese, Italy), I. Adcock (London, United Kingdom), G. Caramori (Messina, Italy), F. Ricciardolo (Torino, Italy)
Source: International Congress 2022 – COPD: from biomarkers to phenotypes and severity
Session: COPD: from biomarkers to phenotypes and severity
Session type: Thematic Poster
Number: 3873
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Di Stefano (Veruno (NO), Italy), I. Gnemmi (Veruno (NO), Italy), F. Dossena (Veruno (NO), Italy), U. Rosani (Padova, Italy), P. Brun (Padova, Italy), A. Leonardi (Padova, Italy), B. Balbi (Padova, Italy), F. Nucera (Messina, Italy), V. Carriero (Torino, Italy), F. Bertolini (Torino, Italy), S. D'Anna (Telese, Italy), M. Maniscalco (Telese, Italy), I. Adcock (London, United Kingdom), G. Caramori (Messina, Italy), F. Ricciardolo (Torino, Italy). Bone Morphogenic Proteins and their antagonists in the lower airways of stable COPD patients. 3873
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|